Lord, Abbett & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $74.6M | Sell |
|
|||||
|
2021
Q2 | $89.2M | Sell |
|
|||||
|
2021
Q1 | $168M | Buy |
|
|||||
|
2020
Q4 | $160M | Buy |
|
|||||
|
2020
Q3 | $151M | Sell |
|
|||||
|
2020
Q2 | $150M | Buy |
|
|||||
|
2020
Q1 | $50.7M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $28M | Sell |
|
|||||
|
2019
Q2 | $25.5M | Sell |
|
|||||
|
2019
Q1 | $34.3M | Buy |
|
|||||
|
2018
Q4 | $31.6M | Sell |
|
|||||
|
2018
Q3 | $39.2M | Sell |
|
|||||
|
2018
Q2 | $35.4M | Buy |
|
|||||
|
2018
Q1 | $35.1M | Sell |
|
|||||
|
2017
Q4 | $34.7M | Sell |
|
|||||
|
2017
Q3 | $37.8M | Sell |
|
|||||
|
2017
Q2 | $33.1M | Sell |
|
|||||
|
2017
Q1 | $33M | Sell |
|
|||||
|
2016
Q4 | $36.3M | Sell |
|
|||||
|
2016
Q3 | $38.7M | Sell |
|
|||||
|
2016
Q2 | $55.4M | Buy |
|
|||||
|
2016
Q1 | $28.3M | Sell |
|
|||||
|
2015
Q4 | $43.7M | Sell |
|
|||||
|
2015
Q3 | $39.4M | Buy |
|
|||||
|
2015
Q2 | $36.5M | Sell |
|
|||||
|
2015
Q1 | $124M | Sell |
|
|||||
|
2014
Q4 | $371M | Sell |
|
|||||
|
2014
Q3 | $401M | Buy |
|
|||||
|
2014
Q2 | $180M | Sell |
|
|||||
|
2014
Q1 | $239M | Buy |
|
|||||
|
2013
Q4 | $186M | Buy |
|
|||||
|
2013
Q3 | $140M | Buy |
|
|||||
|
2013
Q2 | $110M | Buy |
|